Investigating the separation and purification of flavonoids extracted from foxtail millet, with an in-depth study on its functions in alleviating metabolic syndrome through suppressing lipid absorption
- PMID: 40285665
- DOI: 10.1002/jsfa.14295
Investigating the separation and purification of flavonoids extracted from foxtail millet, with an in-depth study on its functions in alleviating metabolic syndrome through suppressing lipid absorption
Abstract
Background: Rising living standards alongside high-fat diets (HFDs) have fueled the prevalence of metabolic syndrome (MetS), posing a significant health challenge with limited effective therapies. Foxtail millet is recognized as a health food with rich flavonoids. The objective of this work is to isolate and purify flavonoids from foxtail millet, which have the potential to alleviate MetS and to clarify their mechanism.
Results: Our research combined single-factor experiments and a Box-Behnken design to optimize the extraction processes for millet whole-grain flavonoids (MWGFs) followed by the purification using D101 resin. Components were eluted using varied alcohol concentrations. Additionally, the investigation revealed that MWGF30 notably decreased triglyceride (TG) levels, mitigated lipid uptake in Caco-2 cells induced by free fatty acids, and suppressed lipid absorption in HFD mice while modulating TG, high‑ and low-density lipoprotein cholesterol and total cholesterol levels. Further investigation uncovered that MWGF30 achieved this lipid uptake reduction ability by downregulating the CD36 protein level.
Conclusion: Collectively, MWGF30 demonstrated a potent ability to regulate blood lipids and curb lipid absorption, enhancing our comprehension of millet's benefits and furnishing a scientifically grounded dietary approach for MetS. © 2025 Society of Chemical Industry.
Keywords: CD36; flavonoids; foxtail millet; lipid absorption; metabolic syndrome.
© 2025 Society of Chemical Industry.
References
REFERENCES
-
- Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA et al., Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81:341–354 (2005).
-
- Chen D, Zhao X, Sui Z, Niu H, Chen L, Hu C et al., A multi‐omics investigation of the molecular characteristics and classification of six metabolic syndrome relevant diseases. Theranostics 10:2029–2046 (2020). https://doi.org/10.7150/thno.41106.
-
- Derosa G and Maffioli P, Anti‐obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf 11:459–471 (2012).
-
- Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP and Elisaf MS, Orlistat‐associated adverse effects and drug interactions: a critical review. Drug Saf 31:53–65 (2008).
-
- Borén J, Taskinen MR, Björnson E and Packard CJ, Metabolism of triglyceride‐rich lipoproteins in health and dyslipidaemia. Nat Rev Cardiol 19:577–592 (2022).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
